X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3055) 3055
Book Review (231) 231
Publication (86) 86
Book Chapter (8) 8
Conference Proceeding (8) 8
Dissertation (2) 2
Magazine Article (2) 2
Transcript (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2712) 2712
dobutamine - pharmacology (1968) 1968
animals (1488) 1488
male (1458) 1458
humans (1435) 1435
dobutamine (1189) 1189
female (1106) 1106
hemodynamics - drug effects (725) 725
middle aged (713) 713
cardiac & cardiovascular systems (671) 671
abridged index medicus (625) 625
cardiotonic agents - pharmacology (597) 597
myocardial contraction - drug effects (581) 581
dogs (569) 569
heart rate - drug effects (518) 518
aged (511) 511
blood pressure - drug effects (490) 490
pharmacology & pharmacy (477) 477
adult (469) 469
adrenergic beta-agonists - pharmacology (388) 388
dopamine - pharmacology (361) 361
dobutamine - therapeutic use (346) 346
dose-response relationship, drug (345) 345
echocardiography (339) 339
rats (339) 339
dobutamine - administration & dosage (311) 311
cardiac output - drug effects (300) 300
heart failure - drug therapy (284) 284
dopamine (280) 280
heart - drug effects (276) 276
hemodynamics (264) 264
myocardium - metabolism (263) 263
heart (254) 254
ventricular function, left - drug effects (244) 244
isoproterenol - pharmacology (243) 243
heart failure (238) 238
catecholamines - pharmacology (232) 232
oxygen consumption - drug effects (232) 232
infusions, intravenous (231) 231
peripheral vascular disease (226) 226
cardiotonic agents - therapeutic use (217) 217
physiology (207) 207
in vitro techniques (201) 201
heart failure - physiopathology (199) 199
swine (190) 190
time factors (189) 189
surgery (188) 188
stroke volume - drug effects (181) 181
coronary circulation - drug effects (178) 178
blood-flow (171) 171
prospective studies (162) 162
norepinephrine - pharmacology (158) 158
anesthesiology (157) 157
vascular resistance - drug effects (154) 154
myocardial contraction - physiology (150) 150
critical care medicine (148) 148
blood pressure (144) 144
cardiology (143) 143
mice (139) 139
heart-failure (138) 138
vasodilator agents - pharmacology (138) 138
disease models, animal (132) 132
adrenergic beta-antagonists - pharmacology (130) 130
milrinone (130) 130
electrocardiography (129) 129
epinephrine - pharmacology (128) 128
septic shock (127) 127
cardiotonic agents - administration & dosage (123) 123
coronary disease - physiopathology (123) 123
catecholamines (122) 122
heart - physiopathology (122) 122
medicine & public health (122) 122
stimulation, chemical (121) 121
norepinephrine (120) 120
analysis (117) 117
cardiac output (117) 117
ventricular function, left - physiology (117) 117
exercise (116) 116
heart rate (116) 116
cardiotonic agents (115) 115
perfusion (115) 115
heart - physiology (114) 114
infusion (113) 113
propranolol - pharmacology (113) 113
myocardial contraction (111) 111
pressure (107) 107
ischemia (104) 104
research (103) 103
dysfunction (102) 102
dopamine - therapeutic use (101) 101
physiological aspects (101) 101
pyridazines - pharmacology (101) 101
rats, sprague-dawley (101) 101
care and treatment (100) 100
mortality (100) 100
coronary-artery disease (99) 99
sepsis (99) 99
epinephrine (98) 98
contractility (96) 96
levosimendan (94) 94
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2885) 2885
Japanese (66) 66
French (32) 32
German (27) 27
Spanish (17) 17
Italian (10) 10
Chinese (9) 9
Russian (8) 8
Portuguese (4) 4
Korean (3) 3
Dutch (2) 2
Bulgarian (1) 1
Czech (1) 1
Danish (1) 1
Lithuanian (1) 1
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE, ISSN 0028-0836, 01/2011, Volume 469, Issue 7329, pp. 241 - 244
beta-adrenergic receptors (beta ARs) are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins upon binding catecholamine agonist ligands... 
CRYSTALLIZATION | AMINO-ACID | ACTIVATION | LIGAND-BINDING | BETA-ADRENERGIC-RECEPTORS | PROTEIN-COUPLED RECEPTOR | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | CRYSTALLOGRAPHY | HIGH-AFFINITY BINDING | BETA-ADRENERGIC RECEPTOR | Dobutamine - metabolism | Hydroxyquinolines - chemistry | Catecholamines - metabolism | Albuterol - pharmacology | Amphetamines - pharmacology | Adrenergic beta-1 Receptor Antagonists - pharmacology | Crystallography, X-Ray | Adrenergic beta-1 Receptor Agonists - chemistry | Structure-Activity Relationship | Receptors, Adrenergic, beta-1 - chemistry | Adrenergic beta-1 Receptor Agonists - pharmacology | Turkeys | Adrenergic beta-1 Receptor Antagonists - chemistry | Drug Design | Adrenergic beta-1 Receptor Antagonists - metabolism | Dobutamine - chemistry | Isoproterenol - chemistry | Binding Sites | Hydroxyquinolines - pharmacology | Amphetamines - chemistry | Drug Partial Agonism | Albuterol - metabolism | Hydroxyquinolines - metabolism | Isoproterenol - metabolism | Models, Molecular | Receptors, Adrenergic, beta-1 - metabolism | Serine - chemistry | Serine - metabolism | Dobutamine - pharmacology | Animals | Hydrogen Bonding | Amphetamines - metabolism | Isoproterenol - pharmacology | Protein Stability - drug effects | Albuterol - chemistry | Ligands | Protein Conformation | Adrenergic beta-1 Receptor Agonists - metabolism | Index Medicus
Journal Article
Psychopharmacology, ISSN 0033-3158, 2012, Volume 219, Issue 2, pp. 327 - 340
The clinical efficacy of the monoamine and noradrenaline transporter inhibitors methylphenidate and atomoxetine in attention deficit/hyperactivity disorder... 
Neurosciences | Biomedicine | Adrenoceptors | Impulsive behaviour | Rat | Attention | Clenbuterol | Pharmacology/Toxicology | Psychiatry | Noradrenaline | CORTICAL FUNCTION | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | NORADRENERGIC MODULATION | NEUROSCIENCES | REACTION-TIME-TASK | PREFRONTAL CORTEX | DEFICIT/HYPERACTIVITY DISORDER | WORKING-MEMORY PERFORMANCE | BEHAVIORAL FLEXIBILITY | PHARMACOLOGY & PHARMACY | LOCUS-COERULEUS NEURONS | BETA-2-ADRENERGIC AGONIST | Choice Behavior - drug effects | Rats, Wistar | Rats | Adrenergic Agonists - pharmacology | Clenbuterol - pharmacology | Male | Methylphenidate - pharmacology | Dobutamine - pharmacology | Dose-Response Relationship, Drug | Desipramine - pharmacology | Animals | Phenylephrine - pharmacology | Isoproterenol - pharmacology | Reaction Time - drug effects | Attention - drug effects | Clonidine - pharmacology | Serial Learning - drug effects | Inhibition (Psychology) | Analysis | Clonidine | Inhibitor drugs | Animal behavior | Rodents | Psychopharmacology | Animal cognition | Index Medicus | alpha 2-Adrenergic receptors | Translation | Desipramine | Attention deficit hyperactivity disorder | Cognitive ability | clonidine | Reaction time task | phenylephrine | Adrenergic receptors | Norepinephrine | Methylphenidate | Neurotransmission | monoamines | Original Investigation
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2011, Volume 108, Issue 31, pp. 12931 - 12936
Long-term memory (LTM) consolidation requires the synthesis of plasticity-related proteins (PRPs). In addition, we have shown recently that LTM formation also... 
Training | Learning | Receptors | Dentate gyrus | N methyl D aspartate receptors | Protein synthesis | Memory | Long term potentiation | Hippocampus | Vehicles | Synaptic tagging | CA1 | HIPPOCAMPAL CA1 | RAT | LATE-PHASE | MULTIDISCIPLINARY SCIENCES | LATE MAINTENANCE | LTP | PROTEIN-SYNTHESIS | dentate gyrus | synaptic tagging | LOCUS-COERULEUS | RECEPTOR ACTIVATION | LONG-TERM POTENTIATION | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Rats, Wistar | 2-Amino-5-phosphonovalerate - pharmacology | Receptors, N-Methyl-D-Aspartate - metabolism | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Male | Memory, Short-Term - physiology | Receptors, Dopamine D1 - metabolism | Adrenergic beta-Antagonists - pharmacology | Exploratory Behavior - physiology | Propranolol - pharmacology | Neuronal Plasticity - physiology | CA1 Region, Hippocampal - metabolism | Receptors, Adrenergic, beta - metabolism | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - metabolism | Receptors, Dopamine D1 - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Memory, Long-Term - drug effects | Rats | Memory, Short-Term - drug effects | Excitatory Amino Acid Antagonists - pharmacology | Avoidance Learning - physiology | Benzazepines - pharmacology | Memory, Long-Term - physiology | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists & inhibitors | Dobutamine - pharmacology | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | 2-Amino-5-phosphonovalerate - analogs & derivatives | Receptors, Dopamine D5 - antagonists & inhibitors | Receptors, Dopamine D5 - metabolism | Physiological aspects | Methyl aspartate | Brain | Genetic aspects | Proteins | Molecules | Neurotransmitters | Rodents | Animal memory | Dopamine D5 receptors | Protein kinase A | Avoidance learning | Glutamic acid receptors (ionotropic) | Extracellular signal-regulated kinase | N-Methyl-D-aspartic acid receptors | Dopamine D1 receptors | Long term memory | Norepinephrine | Glutamatergic transmission | Short term memory | Index Medicus | Biological Sciences
Journal Article
Journal Article
Journal of Surgical Research, ISSN 0022-4804, 2013, Volume 183, Issue 2, pp. 509 - 516
Abstract Background It has been reported that the induction of heme oxygenase-1 (HO-1) mediated by β1-adrenergic receptor inhibits high mobility group box 1... 
Surgery | Myocardial ischemia and reperfusion | Dobutamine | High mobility group box 1 protein | Heme oxygenase-1 | SURGERY | CELLS | HO-1 INDUCTION | MACROPHAGES | HMGB1 RELEASE | ISCHEMIA-REPERFUSION INJURY | HEART | INFARCTION | LIPOPOLYSACCHARIDE | IMPROVE SURVIVAL | EXPRESSION | Heme Oxygenase-1 - metabolism | Oxidative Stress - physiology | Protoporphyrins - pharmacology | Heme Oxygenase-1 - drug effects | Male | Phosphatidylinositol 3-Kinases - metabolism | Adrenergic beta-1 Receptor Agonists - pharmacology | HMGB1 Protein - metabolism | Phosphatidylinositol 3-Kinases - drug effects | p38 Mitogen-Activated Protein Kinases - metabolism | Chromones - pharmacology | Dobutamine - therapeutic use | HMGB1 Protein - antagonists & inhibitors | Disease Models, Animal | Heart - physiopathology | Adrenergic beta-1 Receptor Agonists - therapeutic use | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Rats | HMGB1 Protein - drug effects | Imidazoles - pharmacology | Rats, Sprague-Dawley | Dobutamine - pharmacology | Myocardial Reperfusion Injury - metabolism | p38 Mitogen-Activated Protein Kinases - drug effects | Animals | Heart - drug effects | Pyridines - pharmacology | Oxidative Stress - drug effects | Myocardial Reperfusion Injury - prevention & control | Chromosomal proteins | Cardiotonic agents | Heme | Cardiac glycosides | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article